Zdrowie i gospodarka · 03/05/2023

FDA Releases Draft Guidance on Decentralized Clinical Trials

The US Food and Drug Administration (FDA) has published a draft guidance document outlining recommendations for implementing decentralized clinical trials (DCTs) for pharmaceuticals, biological products, and medical devices, allowing for more flexibility in trial locations.